Tetratherix Ltd.
ASX: TTX.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- William Anthony Knox
- Employees
- 15
- Headquarters
- Alexandria, Australia
- IPO year
- 2025
- Market cap
- A$252.8M
- Website
- https://tetratherix.com
Loading TTX…
Loading profile data…Frequently asked questions about TTX
What does Tetratherix Ltd. (TTX.AX) do?
Tetratherix Ltd. engages in biomaterial and regenerative medicine business in Australia and internationally. The company has used its Tetramatrix platform technology to manufacture and provide products in the areas of bone regeneration, tissue spacing, and tissue healing applications. Tetratherix Limited was incorporated in 2015 and is based in...
Where does TTX.AX trade?
Tetratherix Ltd. (TTX.AX) trades on the Australian Securities Exchange.
What sector is TTX.AX in?
Tetratherix Ltd. (TTX.AX) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Tetratherix Ltd.?
William Anthony Knox is the chief executive officer of Tetratherix Ltd. (TTX.AX).
Where is Tetratherix Ltd. headquartered?
Tetratherix Ltd. is headquartered in Australia.
Does TTX.AX pay a dividend?
Tetratherix Ltd. (TTX.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TTX.AX go public?
Tetratherix Ltd. (TTX.AX) completed its initial public offering in 2025.